Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative IVC-US Guided Fluid Optimization and Ondansetron to Prevent Hypotension
NCT05784350Not yet recruiting
- Sponsor
- Meir Medical Center
- Start
- Feb 2027
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ondansetron in hypotension (3 arms), sponsored by Meir Medical Center. Primary endpoint: Incidence of hypotension after the induction of general anesthesia at 5 years. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
ondansetron
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05784350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05784350.